title: Bortezomib and bone health in adults: can we extend these findings to children?
authors.forename: Emma
authors.initials: E
authors.lastname: Eriksson
authors.forename: Lars
authors.initials: L
authors.lastname: Sävendahl
authors.forename: Farasat
authors.initials: F
authors.lastname: Zaman
mesh_terms: D000328:Adult; D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001862:Bone Resorption / Q000139:chemically induced*; D001897:Boronic Acids / Q000009:adverse effects* / Q000627:therapeutic use; D000069286:Bortezomib; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D051379:Mice; D009101:Multiple Myeloma / Q000188:drug therapy; D011719:Pyrazines / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib